Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

507.58 +4.88 (+0.97%)

Streaming Delayed Price Updated: 10:29 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

United Therapeutics and Miromatrix Medical Announce Successful Tender Offer

December 12, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024

December 07, 2023

From United Therapeutics Corporation

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)

November 13, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

United Therapeutics: A Strong Quarter But What About 2024? ↗

August 15, 2023

United Therapeutics had strong Tyvaso sales but it highlights the investor debate heading into 2024.

Via Talk Markets

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

Flying Car Stocks: What a Devastating Short Report Means for EHang ↗

November 08, 2023

Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.

Via InvestorPlace

EH Stock Alert: Hindenburg Slams EHang in New Short Report ↗

November 07, 2023

EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.

Via InvestorPlace

United Therapeutics Corporation Reports Third Quarter 2023 Financial Results

November 01, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis

October 31, 2023

From United Therapeutics Corporation

Via Business Wire

What 4 Analyst Ratings Have To Say About United Therapeutics ↗

August 03, 2023

Via Benzinga

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023

October 31, 2023

From United Therapeutics Corporation

Via Business Wire

Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical ↗

October 30, 2023

Via Benzinga

Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today? ↗

October 30, 2023

United Therapeutics Corporation (NASDAQ: UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ: MIRO) for $3.25 per share in cash (an aggregate of approximately $91 million).

Via Benzinga

Why Is Miromatrix Medical (MIRO) Stock Up 235% Today? ↗

October 30, 2023

Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 30, 2023

It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!

Via InvestorPlace

United Therapeutics to Acquire Miromatrix Medical

October 30, 2023

From Miromatrix Medical Inc.

Via GlobeNewswire

United Therapeutics to Acquire Miromatrix Medical

October 30, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023

October 25, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs

September 22, 2023

From United Therapeutics Corporation

Via Business Wire

Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023 ↗

September 20, 2023

Defensive stocks have always been the go-to investments for those looking to protect their long-term portfolio and weather downturns.

Via InvestorPlace

United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report

September 12, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

September 01, 2023

From United Therapeutics Corporation

Via Business Wire

The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗

August 17, 2023

This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.

Via InvestorPlace

United Therapeutics Corporation Reports Second Quarter 2023 Financial Results

August 02, 2023

From United Therapeutics Corporation

Via Business Wire

If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names ↗

July 26, 2023

These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.

Via InvestorPlace

United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023

July 26, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

July 24, 2023

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Unveils Net Zero Energy Distribution Center

June 14, 2023

From United Therapeutics Corporation

Via Business Wire

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

May 18, 2023

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

Via MarketBeat

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.